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In Sebastiani et al “Genetic signatures of exceptional 
longevity in humans” [1], we presented the results from 
a genome wide association study of exceptional 
longevity in 801 centenarians from the New England 
Centenarian Study (NECS, mean age at death 104 
years) and 914 genetically matched controls.  The  study  
 
 













































identified a group of 281 SNPs that, used jointly in a 
genetic risk model, had 60% sensitivity to discriminate 
between centenarians and healthy controls. The 
sensitivity of the model however increased with more 
extreme ages of the centenarians and reached 85% for 
subjects age>107 years. The 281 SNPs included 
rs2075650 in TOMM40/APOE that reached irrefutable 
genome-wide significance and replicated in an 



























Abstract: Despite  evidence  from  family  studies  that  there  is  a  strong  genetic  influence  upon  exceptional  longevity,
relatively few genetic variants have been associated with this trait. One reason could be that many genes individually have
such weak  effects  that  they  cannot meet  standard  thresholds  of  genome wide  significance,  but  as  a  group  in  specific
combinations of genetic variations, they can have a strong influence. Previously we reported that such genetic signatures
of 281 genetic markers associated with about 130 genes can do a relatively good job of differentiating centenarians from
non‐centenarians particularly  if  the  centenarians  are 106  years  and older. This would  support our hypothesis  that  the
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independent cohort of 253 nonagenarians and 
centenarians from the Elixir Pharmaceuticals Study of 
Extreme Longevity and 341 genetically matched 
controls. The other 280 SNPs were statistically 
significant with p-values ranging between 10-2 and 10-
6 although their level of significance did not meet the 
stringent criterion for genome-wide significance of 
5x10-8, thus raising the possibility that these 
associations could be false positives. We therefore set 
out to determine which of these 281 SNPs were 
associated with longevity in a meta-analysis  that 
included the two original studies, in addition to a case 
control study of longevity with nonagenarians and 
centenarians from the Southern Italian Centenarian 
Study [2],  and a case control study of nonagenarians 
and centenarians from the Long Life Family Study [3].  






































data of a subset of SNPs from the Japanese Centenarian 
Study [4] .  
   
RESULTS 
 
Table 1 lists the studies’ characteristics. The ELIX, 
SICS, LLFS and JCS case-control studies were all 
smaller than the NECS and cases in the ELIX, SICS and 
LLFS were younger than the NECS.  Controls in the 
LLFS were males who died by the age of 94 or females 
who died by the age of 95, and 85% of these controls 
are relatives of the cases (eg siblings who died at 
younger ages) from the same family of the cases, so that 
they provide the strongest type of genetic matching. 
Some of the controls in the NECS and ELIX studies 
were chosen from the Illumina repository of controls 









































Study Population Symbol N Cases  Age of Cases  N Controls Age of Controls  Genotyping Platform 
Elixir Pharmaceutical 




Study JCS 513 106 (100-114) 561   69 (19-89) Affymetrix 500KEA/500K/5.0 
Long Life Family Study LLFS 738 98 (95-110) 356  91 (44-95) Illumina Omni 2.5 
New England 
Centenarian Study NECS 801 104 (95-119) 914   73 (53-90)
(1) Illumina 370/550/610/1M 
Southern Italian 
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In the meta-analysis of additive genetic associations in 
NECS, ELIX, SICS and LLFS, 10 SNPs reached 
statistically significant association after Bonferroni 
correction (p-value < 0.05/280=0.00018). An additional 
4 SNPs reached Bonferroni corrected statistical 
significance using a dominant model for the top-strand 
allele, and two SNPs reached Bonferroni corrected 
statistically significance using a recessive model for the 
top-strand allele (Table 2). The number of significant 
associations was much larger when a 5% and 6% false 
discovery rate corrections were used (Supplement Table 
1). The Venn diagram in Figure 1 shows the number of 
significant SNPs from the meta-analysis of additive, 
dominant and recessive models, and 128 SNPs reached 
statistical significance with 6% false discovery rate. 
Note the substantial overlapping between the results 
with different genetic models. In fact, the 3 parameters 
of the additive, dominant and recessive models are 
functionally related and the tests are not independent.  
The full list of results for the meta-analysis of the 280 



























































































from  the  meta‐analysis  of  additive,  dominant  and  recessive  models
when a 6% false discovery rate (FDR) was used. Genotypes were called










OR MetaOR (95% CI) pval 
1 rs2075650 TOMM40/APOE A/G 0.925 G 0.492 0.726 0.499 0.507 0.527 (0.452;0.616) 4.44E-16 
2 rs1525501 NA A/G 0.128 G 0.761 0.836 0.510 0.719 0.724 (0.630;0.831) 4.94E-06 
            
3 rs3803833 NA A/C 0.875 C 0.712 0.974 0.856 0.667 0.765 (0.675;0.867) 2.72E-05 
4 rs1016013 NA A/G 0.373 G 1.300 1.168 1.186 1.089 1.206 (1.105;1.317) 2.87E-05 
            
5 rs216148 CSF1R A/G 0.124 G 0.692 1.011 0.550 0.798 0.753 (0.655;0.865) 6.36E-05 
6 rs1867102 C9orf3 A/G 0.477 G 1.295 1.144 1.107 1.117 1.195 (1.094;1.304) 7.28E-05 
7 rs1822590 NA A/C 0.277 C 1.309 1.120 1.109 1.190 1.208 (1.100;1.327) 7.57E-05 
8 rs4918255 SORCS1 A/G 0.665 G 1.265 1.103 1.180 1.238 1.212 (1.101;1.333) 8.81E-05 
9 rs1456669 NA A/C 0.160 C 0.638 0.835 1.118 0.817 0.777 (0.685;0.882) 9.89E-05 
10 rs915179 LMNA A/G 0.541 G 1.342 1.112 1.198 0.999 1.191 (1.090;1.301) 0.00010 
            
11 rs2738679 WWOX A/G 0.700 GG 1.840 1.213 1.802 1.587 1.600 (1.270;2.017) 6.85E-05 
12 rs17702471 GPC6 A/G 0.785 GG 2.512 1.673 1.613 1.142 1.810 (1.347;2.431) 8.33E-05 
13 rs1042663 C2 A/G 0.109 GG 0.617 0.808 0.629 0.988 0.720 (0.612;0.848) 8.386E-05 
14 rs651922 DCPS A/G 0.724 GG 2.312 1.035 2.040 1.079 1.650 (1.270;2.145) 0.00018 
15 rs11218921 NA A/G 0.920 AG/GG 0.502 0.655 0.810 0.523 0.590 (0.457;0.762) 5.47E-05 































Only 19 SNPs in the set of 28that reached FDR 
corrected significance had genotype data available in 
the JCS set, and the meta-analysis of these 19 SNPs was 
extended to include the results for the JCS set Six SNPs 
(see Table 3) reached Bonferroni corrected significance 
(p-value< 0.0026=0.05/19) in the meta-analysis of 
results from additive models (4 SNPs),dominant models 
(1 SNP), and recessive models (1 SNP) and 4 of these 6 
SNPs were not included in the list of 16 that reached 
Bonferroni corrected significance in the meta-analysis 
of NECS, ELIX, SICS and LLFS. Fourteen SNPs in 19 
reached 6% FDR corrected statistical significance. Full 
details of the analysis that included the JCS set is in 














































































Row SNP Gene Allele A.AF1 CA2 NECS.OR SICS.OR ELIX.OR JCS.OR LLFS.OR MetaOR pval 
1 rs1525501 NA A/G 0.128 G 0.761 0.836 0.510 0.949 0.719 0.807 (0.725;0.898) 8.97E-05 
2 rs1456669 NA A/C 0.160 C 0.638 0.835 1.118 0.937 0.817 0.825 (0.743;0.916) 0.000312 
3 rs4729049 CDK6 A/G 0.889 G 1.357 1.170 1.132 1.201 1.085 1.212 (1.078;1.362) 0.001311 
             
4 rs11954180 SLC6A7 A/G 0.058 G 1.540 1.214 1.401 0.915 1.022 1.302 (1.105;1.535) 0.001639 
             
5 rs2596230 RYR3 A/G 0.876 GG 4.175 2.755 3.099 1.099 0.893 2.607 (1.536;4.423) 0.000383 





Figure  3.  Genes  with  SNPs  that  reach  statistical 
significance  with  meta‐analysis  and  were  implicated  in
Alzheimer’s and coronary artery disease.   The two networks 
display 38 genes  linked to Alzheimer's disease (top) and 24 genes 
linked  to  coronary artery disease  (bottom)  that  included SNPs  in 
the  list  of  281  in  [1].  Genes  circled  in  blue  include  SNPs  that 
reached statistical significance in the meta‐analysis. 
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The list of 28 SNPs include both common and 
uncommon variants that are associated with increase 
odds for extreme longevity. Figure 2 plots of genetic 
effects for different genetic models versus the frequency 
of coded alleles and shows that both uncommon 
variants (allele frequency < 0.05 or > 0.95) and 
common variants are associated with increased odds for 
longevity. Common variants tend to have more modest 
effects than rare variants. 
 
Figure 3 shows two networks of genes associated with 
Alzheimer’s and coronary artery disease that included 
SNPs in the list of 281 reported in Sebastiani et al [1]. 
Nodes circled in blue in the Figure show the genes that 
include SNPs reaching statistical significance in the 
meta-analysis (20 of 38 genes associated with 
Alzheimer’s disease, and 14 of 24 genes associated with 




After the publication of the article by Sebastiani et al [1] 
that presented the corrected results from an article 
published online in Science Express and then retracted 
because of technical errors [5], there was discussion 
about the validity of the 281 SNPs associated with 
exceptional  longevity  (http://blog.23andme.com/news/ 
studies-of-extreme-longevity-extremely-challenging/)  
and confusion about the correct SNP list associated with 
exceptional longevity [6].  The main objective of this 
article was therefore to cast some light on the validity of 
the individual associations of the 281 longevity SNPs.  
The meta-analyses of 5 case control studies of 
exceptional longevity of Caucasians and Japanese 
identified 0 SNPs that reached Bonferroni corrected 
significance, and 128 that reached statistical 
significance with a 6% false discovery rate. Besides 
arbitrary thresholds for statistical significance, the 
concordance of genetic effects for many of the SNPs 
across the 5 different studies is also providing evidence 
of true associations (See Tables 2 and 3, and the 
supplementary tables for SNPs that reached significance 
with 5% FDR correction).  The large number of 
replicated SNPs provides further support for the 
hypothesis that exceptional longevity is a multifactorial 
trait that is determined in part by an enrichment for 
common genetic variants imparting protective effects 
[1, 7, 8]. The rare existence of families that demonstrate 
clustering for extreme age also suggests the existence of 
rare variants as well [9]. 
 
The list of 128 SNPs include common and uncommon 
variants that are associated with increased odds for 
exceptional longevity (Figure 2). The common variants 
have modest effects and although they reach statistical 
vsignificance when the multiple correction penalty is 
limited to 280 tests, they would fail to reach statistical 
significance at genome-wide level. This result is 
consistent with other genetic studies of aging and 
longevity that failed to discover SNPs reaching genome 
wide significance even with substantially larger sample 
sizes [10-13], although these variants can be predictive of 
lifespan [14]. Some of the variants in Tables 2 and 3 are 
associated with decreased odds for exceptional longevity. 
It is interesting to note that lack of  deleterious variants is 
not a major feature of these genetic data and we and 
others indeed showed that centenarians do not appear to 
differ in the number of deleterious variants compared to 
healthy controls [1, 15, 16].  
 
Some of the SNPs listed in Tables 2 and 3 are in genes 
previously associated with underlying mechanisms of 
aging and age related diseases, and Figure 3 shows an 
example of replicated genes previously associated with 
Alzheimer’s disease and coronary artery disease. The 
best known longevity variant in Table 2 is rs2075650 in 
TOMM40 and linked to APOE. This result is consistent 
with those reported by other studies [6, 11] and by the 
recent linkage analysis in [17]. The SNP rs2075650 was 
linked to the ɛ4 allele of the APOE gene although the 
strength of linkage disequilibrium between rs2075650 
and the SNPs rs7412 and rs429358 that define the 3 
alleles of APOE seems to vary with ethnicity. The 
Leiden Longevity Study reported a r2=0.56 between 
rs2075650 and rs429358 in 8946 subjects [11], while in 
4576 subjects of the LLFS the r2 between rs2075650 
and rs429358 was only 0.27 [19]. The association 
between the SNP rs2075650 and the ε4 allele is stronger 
at the genotype level and in LLFS subjects, 88% of 
carriers of the GG genotype carried at least one copy of 
the ɛ4 allele, compared to 73% prevalence of the ɛ4 
allele in carriers of the AG genotype and 6% in carriers 
of the AA genotype.  Interestingly, the effect of the G 
allele was more modest in the SICS set. This result is 
also consistent with the known variability of APOE 
alleles with ethnicities [19]. Unfortunately SNP data 
were not available for assessment of this association in 
the JCS set.  Note that. SNPs in the Alzheimer’s disease 
associated genes CEACAM16, CSFR1, SORCS1, 
WWOX and DEFB1 (Figure 3) also reached Bonferroni 
corrected significance. 
 
The SNP rs915179 in LMNA showed consistent effects 
in the NECS, ELIX and SICS sets but not the LLFS set, 
although the association reached Bonferroni corrected 
statistical significance in the meta-analysis of Caucasian 
studies. This result is consistent with recent findings in 
[20] and the data included in this analysis partially 
overlap with those included in [20]. The synonymous 
coding SNP rs4641 is in moderate LD with rs915179 
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and we noted that two supercentenarians (ages at death 
> 114 years) were both heterozygous carriers of this 
mutation [21] which was associated with survival 
advantage as well as increased chance for metabolic 
trait. One study suggested that this advantage is related 
to increased body mass index (BMI) [22] that in the 
very old could compensate the effects of sarcopenia and 
osteoporosis. Supporting an important role of BMI and 
longevity is the significant association of the SNP 
rs3906146 in LMX1B and rs9899404 in GIP 
(Supplement Table 1, FDR < 6%). The SNP rs3906146 
is in moderate LD with the less common SNP rs867559 
(r2=0.32, D’=1, based on CEPH from HapMap) that 
was found associated with high BMI and obesity in 
[24]. These results are in agreement with an important 
role of insulin and longevity [25, 26].  Two SNPs in the 
WRN gene reached statistical significance in the meta-
analysis of Caucasian studies (rs3024239 and 
rs1800392, Supplement Table 1, FDR < 6%). The 
association of rs1800392 became significant at 5% 
Bonferroni corrected significance when the meta-
analysis included the JCS set (Supplement Table 2).   
 
The G allele of SNP rs2596230 in RYR3 (Table 3) 
showed consistent recessive effects in all the studies 
(Meta OR=2.61). This SNP has been associated with 
age-related macular degeneration [26]. Note that Table 
2 includes an additional SNP (rs216148 in CSF1R) that 
replicates in the ELIX set that has also been linked to 
age-related macular degeneration [27]. 
 
Limitations. Although this study represents the largest 
meta-analysis of exceptional longevity to date, the overall 
sample size is still relatively small to capture small 
genetic effects. The LLFS set is very large compared to 
the other studies, but most of the participants are still 
alive and younger and the LLFS will become much more 
powerful over time as these individuals achieve older 
ages. In addition, the median ages at death in the ELIX, 
SICS and LLFS sets were younger than the median age at 
death of 104 years in centenarians of the NECS and this 
difference in ages as well as birth cohort differences may 
have limited the replication rate.   An additional 
limitation is that although we included studies of 
different ethnicities and race, the JCS samples were 
genotyped with a different genotyping platform and 
imputation failed, so that the majority of the SNPs in the 
list of 281 could not be tested and additional genotyping 
and sequencing are necessary. Additional replication 
studies will provide further evidence in support of these 
and perhaps other associations. 
 
MATERIAL AND METHODS 
 
Ethic Statement. The NECS protocol is approved by the  
Boston University Medical Campus Institutional 
Review Board. The ELIX enrollment protocol was 
approved by the Western Institutional Review Board. 
The SICS study protocol is overseen and approved by 
the Multimedica Hospital Institutional Review Board in 
Milan (Italy). The JCS study protocol is approved by 
the Ethical Committee of Keio University School of 
Medicine. Participants of the LLFS underwent informed 
consent and the study was approved by the Institutional 
Review Boards of Boston University Medical Campus, 
University of Pittsburgh, Columbia University and 
Washington University St Louis, and the Ethics Board 
of the University of Denmark. 
 
Study Populations and Genotype Data. All studies are 
summarized in Table 1. 
 
The NECS case-control set of 801 centenarians and 914 
genetically matched controls is described in [1]. The 
study included centenarians from the NECS [28] 
(median survival 104 years, age range 95-119) and a 
combination of controls from the NECS (median age 73 
years, age range 50-93) and from the Illumina control 
database (iControlDB). Ages were unknown for the 
majority of Illumina controls. The algorithm for genetic 
matching was described in [29]. The data were 
genotyped using Illumina arrays 370, 610 and 1M, and 
the final list of 281 SNPs passed stringent quality 
control measures, including a sample call rate >96% 
and a SNP call rate >98% in all array types. For 
independent validation of the genotype data, the top 30 
SNPs included in the list were also genotyped using the 
TaqMan, with a concordance >99%. All details are 
described in [1] and its online supplement material.  
 
The Elixir study, also described in [1], included 253 
long lived individuals (median survival 100 years; age 
range: 89-114) and 341 genetically matched controls. 
The long lived individuals were enrolled by Elixir 
Pharmaceuticals between 2001 and 2003 using a 
protocol that matched the NECS and samples were 
genotyped using the Illumina 370 and 610 arrays. The 
genetically matched controls were selected from the 
Illumina control database (iControlDB) using the same 
algorithm used for the NECS data. This study had a 
slightly larger enrichment of subjects with Eastern 
European, Ashkenazi Jewish ancestry compared to the 
discovery set.  
 
The Southern Italian Centenarian Study (SICS) included 
410 nonagenarians and centenarians (median survival 
96, age range 90-109) and 553 geographically matched 
controls. The nonagenarians and centenarians were 
recruited by the Institute Longevita in Italy, beginning 
in 2003, using recruitment and data collection modeled 
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after the NECS protocol. All DNA samples were 
genotyped using Illumina 317 and 370 arrays and the 
data were described in [2].  
 
The Japanese Centenarian Study (JCS) included 513 
long lived individuals (median survival 106 years; age 
range 100-114) and 561 geographically matched 
controls (median age 75 years; range: 26-89).  The JCS 
enrolls Japanese centenarians from throughout Japan 
with an emphasis upon recruiting semi-
supercentenarians (age 105+ years) and referent cohort 
subjects comprising spouses of centenarians’ offspring 
and healthy younger volunteers. DNA samples were 
genotyped using the Affymetrix 500KEA, 500K, and 
5.0 arrays with protocols described in [4].  
 
The Long Life Family Study (LLFS) enrolled families 
enriched for longevity via 4 field centers (Boston, New 
York, and Pittsburgh in the USA, and Denmark) 
between 2006 and 2009 and participants are followed 
annually to update vital, medical and functional status. 
The recruitment protocol, described in [3], used the 
Family Longevity Selection Score (FLoSS) for an 
objective measure of familial longevity [30] and 
enrolled 583 families with a FLoSS > 7 consisting of 
1493 probands, their siblings and 192 spouses in the 
older generation, and 2437 offspring and 809 of their 
spouses. Available to this replication study were 
genome wide genotype data from 4,567 subjects 
generated from the Illumina Omni chip 2.5 (2.5M 
SNPs), imputed to the 1000 genomes using MACH as 
described in [31].  The genotyping protocol, quality 
control and quality assessment included use of the GRR 
program to validate familial relations [32], the program 
Loki to validate Mendelian consistency [33], SNP call 
rate > 98% and sample call rate > 97.5%. LLFS 
participants have been followed since 2006 and 822 
mortality events were noted (median age at death 95 
years, range 44 –110) since enrollment up to April, 
2013. We identified 738 subjects with age at last contact 
>94 years for males, and > 95 years for females 
matching the age threshold for definition of case in the 
NECS, and 356 subjects who died at younger ages and 
used these subjects for a case control study of extreme 
longevity.  
 
SNP selection. All 281 SNPs were available in the ELIX 
and SICS sets. We identified 209 of the 281 SNPs in the 
Illumina Omni arrays used for genotyping the DNA 
samples of the LLFS subjects, while good quality 
imputed data were available for the other 71 SNPs (mean 
r2=0.99), and one SNP could not be included in the 
analysis. The JCS DNA sample set was genotyped with 
Affymetrix arrays and since imputation did not yield 
reliable data, only 32 SNPs were available for replication 
after removal of SNPs with 0 genotype counts.  
  
Analytic approach. A meta-analysis of results was 
conducted using the rmeta package in R 3.01. Standard 
estimates of log-odds ratios and standard errors were 
calculated using allelic, dominant and recessive models 
for the top strand allele in NECS, ELIX, SICS and JCS 
case control studies. Continuity correction was used to 
estimate the log-odds ratios. SNPs alleles (A, B) were 
coded according to the top-strand rule, so the alleles of 
each SNP are either (A, G) or (A, C). Based on these 
alleles, dominant models for the A allele were defined 
by coding the 3 genotypes as AA/AB=0, versus BB=1, 
while recessive models for the A allele were defined by 
coding the 3 genotypes as AA=0 versus AB/BB=1.  
Log-odds ratios and standard errors were estimated 
using a mixed effect logistic regression model in LLFS 
case control study, adjusted for sex and significant 
genome-wide principal components that were estimated 
using eigenstrat [34]. The analysis of mixed effect 
logistic regression for the 3 genetic models was 
conducted in the OpenBUGs software, using vague 
prior distributions and normally distributed random 
effects to account for the within family relation of 
consanguineous subjects. The log-odds ratios of the 5 
case control studies were meta-analyzed using inverse 
variance weights. Woolf’s test of heterogeneity was 
used to decide upon fixed or random effects meta-
analysis on a per-SNP base, and random effect meta-
analysis was conducted for those SNPs in which the 
significance p-value of the test for heterogeneity was < 
0.05/280. Stringent statistical significance was based on 
Bonferroni correction (0.05/280=0.00018 in meta-
analysis of NECS, ELIX, SICS and LLFS results, and 
0.05/21=0.0024 when the analysis was extended to 
include 21 SNPs that reached significance in the 
combined NECS, ELIX, SICS and LLFS studies and 
were available for analysis in the JCS case/control 
study). The Bonferroni correction is however 
unnecessarily stringent because it assume a 0% true 
positive rate in the set of 280. We therefore also used a 
0.05 FDR correction using Benjiamini Hochberg 




The original GWAS of exceptional longevity in 
centenarians from the NECS and genetically matched 
controls generated a substantial list of genetic 
candidates for human longevity that included both novel 
and well established longevity associated genes. The 
large number of SNPs that reached statistical 
significance in this analysis shows that many of these  
 
  
www.impactaging.com                    659                                AGING, September 2013, Vol. 5 No.9
variants are robust and we expect to be able to replicate  
even larger numbers as studies grow in size, their 
subjects become older and hopefully many more studies 
will coordinate their efforts to use similar genotyping 
platforms so that a greater number of markers are 
comparable. Genetic variations associated with 
exceptional longevity that are noted in populations with 
very different genetic backgrounds may be particularly 
interesting and important to identify biologic pathways 
that influence exceptional longevity and processes as 
basic as rate of aging. Although some of the variants in 
Tables 2 and 3 are known to be associated with aging or 
age-related diseases, some of the replicated results point 
to novel genes that may influence aging and extreme 
lifespan and open new avenues of research on the 
genetic of extreme longevity. 
 
The challenge is how to follow up these current results. 
Our multivariate modeling of exceptional longevity in 
[1] showed that different combinations of the 281 SNPs 
alleles determine different probabilities of survival to 
very old ages. Functional experiments that try to assess 
the individual effects of these variants with longevity 
may fail or be suboptimal because they would ignore 
other interacting genetic variants. A systems-based 
approach will be necessary to discover the synergistic 
and antagonistic effects of these many variants and their 
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